Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Size to Grow by USD 106.84 Million at a CAGR of 8.12% from 2022 to 2027 - The rising demand for drug delivery applications to drive the market growth - Technavio
06 Dec 2023
NEW YORK, Dec. 6, 2023 /PRNewswire/ -- The
poly (lactic-co-glycolic acid) (PLGA) market is projected to increase at a
CAGR of 8.12% during the forecast period – 2022 to 2027 by Technavio data analysts and research experts. This market research report also suggests statistics about the market size that will grow by
USD 106.84 million. The rising demand for drug delivery applications, the growing number of surgical advancements, and the rising number of traumatic injuries caused by the increasing road accidents are projected as the key factors leading to the poly (lactic-co-glycolic acid) (PLGA) market share growth.
Continue Reading
Preview
Source: PRNewswire
Technavio has announced its latest market research report titled Global Poly(Lactic-Co-Glycolic Acid) (PLGA) Market 2023-2027
For more such market analysis updates, historic (2017 to 2021), and forecast market size (2023 to 2027),
request for the sample PDF report
.
New Business Opportunities - Market Segments and Key Regions Analysis
As per Technavio's analysis, there are several market segments classified including personal care and dermatology, suture, fracture fixation, and others in the poly (Lactic-Co-Glycolic Acid) (PLGA) market.
Among all these market segments, the personal care and dermatology segment is projected to record the highest market share growth during the forecast period. It was valued at
USD 68.81 million in 2017 and continued to grow significantly by 2021.
Considering the geographical regions for market share growth, North America is projected at top of the list. 35% of the total market share growth will originate from North America by 2027.
Technavio further suggests, cost-effectiveness and the unique functional properties of PLGA and regulatory approval for several PLGA products by government agencies and international regulations support the poly lactic-co-glycolic acid market growth in North America during the forecast period.
For more detailed segment analysis and geographical business distribution, historic (2017 to 2021), and forecast market size (2023 to 2027),
get the exclusive sample PDF report
.
Key Market Driver, Trend, and Challenge
The rising demand for drug delivery applications is significantly driving the Poly (Lactic-Co-Glycolic Acid) (PLGA) market growth.
Technavio also suggests, growing demand for electrospinning and 3D printing technologies will emerge as a primary market trend for growth in the Poly (Lactic-Co-Glycolic Acid) (PLGA) market from 2022 to 2027.
As an emerging market challenge, high prices of the PLGA may impede market growth as per Technavio's report.
What`s New?
Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
Global competitiveness and key competitor positions
Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial -
buy the full report
.
Key Market Vendors
There are a few key vendors operating in the market, mentioned in the report such as:
Ashland Inc.
Avail Technavio's subscription
to get lifetime access to 17,000+ market reports and world-class market intelligence.
Key Data Covered in this Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Report
Projected CAGR of the market during 2023-2027
Detailed statistical information on the major market drivers of the Poly (Lactic-Co-Glycolic Acid) (PLGA) market during 2023-2027
Market size analysis of the Poly (Lactic-Co-Glycolic Acid) (PLGA) market size and its association with the parent market
Relevant predictions about upcoming market trends and detailed consumer behavior analysis
Market share growth analysis across North America, APAC, Europe, South America, and the Middle East and Africa
Detailed market's competitive landscape and key information about market vendors
Comprehensive analysis of various market challenges
Related Reports
The multiple myeloma drugs market is projected to increase at a CAGR of 5.9% during the forecast period – 2022 to 2027 by Technavio data analysts and research experts. This market research report also suggests the statistics about the market size that will grow by USD 6,419.94 million.
The generic drugs market is projected to increase at a CAGR of 7.11% during the forecast period – 2022 to 2027 by Technavio data analysts and research experts. This market research report also suggests statistics about the market size that will grow by USD 176.25 billion.
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.